Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (161-170 of 439) with videos related to

Pageof 44
Sort By:
Molecular Cancer Therapeutics|May 20, 2016
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer TumorsChristopher A Hamm, Diarmuid Moran, Kakuturu Rao, et al.
Breast Cancer Research and Treatment|August 13, 2015
The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based studyYinzhi Lai, Zhong Ye, Jesse M Civan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancerLeslie K Diaz, Massimo Cristofanilli, Xiao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast CancerAnne F Schott, Lori J Goldstein, Massimo Cristofanilli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2010
Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditionsBisrat G Debeb, Wei Xu, Henry Mok, et al.
Scientific Reports|September 3, 2024
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancerSerena Di Cosimo, Marco Silvestri, Cinzia De Marco, et al.
International Journal of Cancer|September 22, 2010
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cellsMichal Mego, Ugo De Giorgi, Shahenaah Dawood, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
Cancer|February 16, 2005
Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinomaMassimo Cristofanilli, Yuko Yamamura, Shu-Wan Kau, et al.
Cancer|December 7, 2006
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapyChafika Mazouni, Angeline Hall, Kristine Broglio, et al.
Pageof 44

Showing results (161-170 of 439) with videos related to

Sort By:
Pageof 44
Molecular Cancer Therapeutics|May 20, 2016
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer TumorsChristopher A Hamm, Diarmuid Moran, Kakuturu Rao, et al.
Breast Cancer Research and Treatment|August 13, 2015
The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based studyYinzhi Lai, Zhong Ye, Jesse M Civan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancerLeslie K Diaz, Massimo Cristofanilli, Xiao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast CancerAnne F Schott, Lori J Goldstein, Massimo Cristofanilli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2010
Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditionsBisrat G Debeb, Wei Xu, Henry Mok, et al.
Scientific Reports|September 3, 2024
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancerSerena Di Cosimo, Marco Silvestri, Cinzia De Marco, et al.
International Journal of Cancer|September 22, 2010
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cellsMichal Mego, Ugo De Giorgi, Shahenaah Dawood, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
Cancer|February 16, 2005
Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinomaMassimo Cristofanilli, Yuko Yamamura, Shu-Wan Kau, et al.
Cancer|December 7, 2006
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapyChafika Mazouni, Angeline Hall, Kristine Broglio, et al.
Pageof 44